None
Quote | X4 Pharmaceuticals Inc. (NYSE:XFOR)
Last: | $ |
---|---|
Change Percent: | -7.04% |
Open: | $9.85 |
Close: | $9.11 |
High: | $10.0371 |
Low: | $9.04 |
Volume: | 29,674 |
Last Trade Date Time: | 02/12/2020 04:41:24 pm |
News | X4 Pharmaceuticals Inc. (NYSE:XFOR)
2024-04-15 18:21:52 ET Summary X4 Pharmaceuticals, Inc. is awaiting an FDA decision on its lead molecule mavorixafor for the treatment of WHIM syndrome. Mavorixafor is a powerful immune system booster with potential in treating rare immunodeficiency. X4's financial position is...
2024-04-08 10:20:00 ET April 8, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Biotech/Life Sciences sectors. The newest biotech companies are involved in preventative care...
Message Board Posts | X4 Pharmaceuticals Inc. (NYSE:XFOR)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $ASNS News Article - Actelis Networks Announces $3.5 Million Private Placement Priced A | whytestocks | investorshangout | 05/04/2023 5:15:46 PM |
whytestocks: $ASNS News Article - Actelis Networks, Inc. Authorizes up to $1 Million Share Repurchas | whytestocks | investorshangout | 11/22/2022 3:05:49 PM |
znewcar1: $XFOR 40% v9,4M c1.25 f68,6M H1.28 YL.88 LL.8595 | znewcar1 | investorshangout | 09/27/2022 8:44:53 PM |
whytestocks: $ASNS News Article - Actelis Networks to Report Fiscal Second Quarter 2022 Financial Re | whytestocks | investorshangout | 08/03/2022 8:35:59 PM |
whytestocks: $ASNS News Article - Actelis Networks Reports Fiscal First Quarter 2022 Results | whytestocks | investorshangout | 06/22/2022 8:35:51 PM |
News, Short Squeeze, Breakout and More Instantly...
X4 Pharmaceuticals Inc. Company Name:
XFOR Stock Symbol:
NYSE Market:
X4 Pharmaceuticals Inc. Website:
2024-04-08 10:20:00 ET April 8, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Biotech/Life Sciences sectors. The newest biotech companies are involved in preventative care...
BOSTON, April 01, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that management will be participating in the upcoming Needham 23 rd Annual Healthcare Conference b...
X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...